Our track record in discovery and development includes more than:
CreaGen API manufacturing pipeline includes:
Our drug product manufacturing includes:
Corporate Data and Government Certification:
CreaGen Inc. operates a cutting-edge 22,000 sq ft research facility situated in Woburn, MA, a key center for life sciences just a short 15-minute drive from Cambridge. Our advanced lab houses 15 chemical and 5 bio-safety hoods, along with state-of-the-art automated systems for parallel synthesis and mass-directed auto purification. These systems facilitate High Throughput Synthesis (HTS) and High Throughput Purification (HTP), accelerating the creation of small molecule libraries. With a 20-year track record in medicinal chemistry and drug discovery, our scientific team has broad expertise in both synthetic and medicinal chemistry. The laboratory is fully equipped to perform a wide range of activities including organic synthesis, medicinal chemistry, lead optimization, biology, and cell culture experiments. This encompasses lead generation and optimization, structure-based drug design, and the complex synthesis of molecules such as nucleosides, nucleotides, and peptides. Our automated lab features high-throughput capabilities and analytical instruments like LCMS, mass-directed purification systems, and NMR, as well as a biochemistry lab outfitted for cell culture—making all these resources immediately available for the project at hand. Our seasoned team has demonstrated success in the field of oncology.
Company Designation
NAICS Codes
Name: CreaGen Inc.
DUNS #: 791218881
CAGE: 4TEG8
UEI: TR7EMJYU1KL9
541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology
541714: Research and Development in Biotechnology (except Nanobiotechnology)